1. Introduction: The Persistent Challenge of Malaria in Nigeria
Malaria remains one of the most significant public health challenges facing Nigeria, which bears the highest malaria burden globally. According to the World Malaria Report 2023, Nigeria accounted for 25.9% of global malaria cases and 30.9% of malaria-related deaths in the African region. With over 51 million cases and approximately 207,000 deaths annually, the disease accounts for nearly 30% of Africa’s total malaria burden.
The impact of malaria extends far beyond immediate morbidity and mortality. The disease places a heavy burden on healthcare facilities, increases child mortality, reduces workforce productivity, contributes to school absenteeism, and impedes Nigeria’s progress toward Sustainable Development Goal 3 (Good Health and Well-being). Approximately 97% of Nigerians—some 173 million people—are at risk of infection, with the disease disproportionately affecting children under five and pregnant women. Children from the lowest socioeconomic backgrounds experience malaria rates seven times higher than those from wealthier families, highlighting the intersection of disease burden with poverty and inequality.
The dominant malaria parasite in Nigeria is Plasmodium falciparum, responsible for 97% of cases, transmitted by the female Anopheles mosquito in warm, humid environments that make tropical regions like Nigeria highly susceptible to year-round transmission.
1.1 The Challenge of Drug Resistance
One of the most daunting challenges in malaria control has been the emergence of drug resistance. Plasmodium falciparum has become increasingly resistant to chloroquine—the most widely used malaria treatment since the 1940s—and sulphadoxine-pyrimethamine, the most common affordable replacement in Africa, is also rapidly losing effectiveness. The continued use of ineffective pharmaceuticals not only contributes to the spread of drug resistance but also causes a disturbing increase in malaria-related morbidity and mortality.
1.2 The Role of Traditional Medicine
Against this backdrop, traditional medicine has remained a cornerstone of healthcare across Nigerian cultures, long before the advent of orthodox medicine. The World Health Organization (WHO) defines traditional medicine as “the culmination of all knowledge, skill, and methods based on the theories, beliefs, and experiences that are specific to all cultures, whether or not they can be explained, and utilized to maintain health as well as to prevent, diagnose, treat, or improve physical and mental illness”.
In Nigeria specifically, approximately 90% of people in rural areas rely solely on herbs for their healthcare needs, and the use of plants for healing purposes predates human history, forming the origin of much modern medicine. The widespread reliance on herbal remedies is driven by multiple factors:
| Factor | Explanation |
| Cost and accessibility | Herbal treatments are often more affordable and widely available than conventional drugs |
| Family traditions | Knowledge of herbal remedies is passed down through generations, forming an integral part of cultural identity |
| Perceived efficacy | Many Nigerians believe herbal remedies are effective against malaria and may have fewer side effects |
| Multi-component nature | The complex composition of herbs may reduce the likelihood of Plasmodium developing resistance |
The WHO estimates that approximately 88% of the world’s population now uses traditional medicine, up from 65% in 1985, reflecting a growing global reliance on these approaches. In Ghana, Mali, Nigeria, and Zambia, the first line of treatment for 60% of children with high fever resulting from malaria is the use of herbal medicine at home.
2. Nigerian Herbal Remedies for Malaria: Scientific Evidence
2.1 SAABMAL®: A Scientifically Validated Polyherbal Formulation
One of the most comprehensively studied Nigerian herbal antimalarial formulations is SAABMAL®, a polyherbal product developed by the National Institute for Pharmaceutical Research and Development (NIPRD) in Abuja. This formulation contains seven medicinal plants:
| Constituent | Botanical Name | Traditional Use |
| Garlic | Allium sativum | Antimicrobial, immune support |
| Lemon grass | Cymbopogon citratus | Fever reduction, digestive health |
| Bitter leaf | Vernonia amygdalina | Antimalarial, digestive issues |
| Sugarcane | Saccharum officinarum | Energy, general wellness |
| Amaranthus | Amaranthus caudatus | Nutritional support |
| Aloe vera | Aloe barbadensis | Wound healing, immune support |
| Sesame | Sesamum indicum | Nutritional, antioxidant |
Key Research Findings:
A rigorous study evaluating SAABMAL® in Plasmodium berghei-infected mice revealed remarkable antimalarial activity:
- Suppressive activity: At 400 mg/kg body weight, SAABMAL® produced 100% suppression of parasitaemia, comparable to the reference drug chloroquine
- Dose-dependent efficacy: Activity ranged from 29.39% at 100 mg/kg to 100% at 400 mg/kg
- Curative potential: At 400 mg/kg, the formulation reduced parasitaemia by 95.80% compared with controls
- Extended survival: Mean survival time of SAABMAL®-treated groups (100 and 200 mg/kg) was higher than that of the chloroquine-treated group
- Safety profile: Histopathological examination showed no pathological changes in the spleen of treated groups
The formulation is ethnomedicinally administered as four capsules (500 mg extracts/capsule) as a start dose, two capsules taken eight hours later, followed by daily dosing for two additional days for the treatment of malaria, as well as for waist pain, arthritis, rheumatism, tuberculosis, and as an adjunct in HIV/AIDS.
2.2 “Herb 25”: A NAFDAC-Registered Herbal Antimalarial
“Herb 25” represents a significant milestone as the first herbal drug registered from a Nigerian University by NAFDAC (National Agency for Food and Drug Administration and Control). This product contains dried powdered leaves of Azadirachta indica (Neem) as the major constituent and is packaged in tea bags for oral administration as a hot water infusion for malaria prevention and treatment.
Phytochemical Profile:
Gas Chromatography-Mass Spectrometric (GC-MS) analysis revealed:
| Extract | Major Terpinoid | Major Fatty Acid |
| Aqueous extract | 7-Oxabicyclo(4.1.0)heptane, 1-methyl-4-(2-methyloxiranyl)- (40.98%) | n-Hexadecanoic acid (28.21%) |
| Ethanolic extract | Naphtho(2,1-b)furan-2,8-dione, decahydro-3a,6,6,9a-tetramethyl- (23.11%) | n-Hexadecanoic acid (32.05%) |
The presence of both terpinoids and fatty acids in significant quantities suggests that “Herb 25” functions as a combined therapy based on the synergistic action of multiple compounds.
2.3 “Agbo-Iba”: Traditional Fever Medicines
The term “Agbo-iba”—meaning “medicine against fever” in the Yoruba language—refers to herbal concoctions used for malaria management, a practice that can be traced back to the 17th century. These formulations typically combine two or more medicinal plants, though the actual composition varies significantly from one herbalist to another in the absence of a formal pharmacopoeia.
Scientific Evaluation:
A comprehensive study evaluated a hepta-herbal Agbo-iba (HHA) formulation commonly used in Benin City, Nigeria:
- In vitro activity: HHA showed moderate potency with an IC₅₀ of 50 μg/ml against the malaria parasite
- Constituent analysis: Of the seven plants, only Annickia affinis (IC₅₀ 1.49 μg/ml) and Sorghum bicolor (IC₅₀ 50 μg/ml) demonstrated antiplasmodial activity, with A. affinis being approximately 34 times more potent
- In vivo efficacy: At 100 mg/kg, HHA suppressed parasite growth by 56.76%
- Synergistic potential: Despite A. affinis being the most active constituent, it showed only 32.46% suppression when used alone, suggesting that other compounds in the formulation enhance its bioavailability or activity
Key Mechanism Discovered:
The study identified quaternary protoberberine alkaloids (QPAs) as the primary active compounds in A. affinis. However, QPAs are substrates of the Permeability glycoprotein (Pgp) efflux pump, which limits their oral bioavailability. The researchers suggested that inhibitors of Pgp present in other HHA constituent plants may improve the bioavailability of QPAs, validating the traditional practice of using polyherbal combinations for enhanced efficacy.
2.4 Eugenia uniflora: A Single-Plant Remedy
Eugenia uniflora leaves are traditionally used in Nigeria for the management of feverish conditions, including malaria, prepared as a decoction of fresh leaves.
Scientific Validation:
A study evaluating the methanolic leaf extract of E. uniflora in mice demonstrated significant antimalarial properties:
| Parameter | Result |
| ED₅₀ (n-hexane fraction) | 52.42 ± 2.12 mg/kg |
| ED₉₀ | (n-hexane fraction) | 95.11 ± 1.76 mg/kg |
| Compound EU1 chemosuppression | 82.79 ± 0.95% |
| Compound EU4 chemosuppression | 79.79 ± 2.32% |
| Survival rate | 60% for both compounds |
Two antimalarial compounds were isolated and characterized:
- EU1: 12-Hydroxy-4,4,8a,10a,15,17a,19-heptamethyl icosahydro picen-3-one
- EU4: 3-(O-α-L-Rhamnopyranosyl)-8-(hydroxymethyl)-4,10,18,21a,22a,22b-(hexamethyl)-5,19-dihydrostigmastane-13-carboxylic acid
These compounds demonstrated IC₅₀ values of 2.64 ± 0.13 and 1.96 ± 0.13 mg/mL respectively in β-hematin assays, confirming their antimalarial activity and validating the traditional use of E. uniflora.
2.5 Jatropha curcas: A Northern Nigerian Remedy
In the Hausa community of Katsina State, the leaves of Jatropha curcas are traditionally used for treating malaria fever.
Research Findings:
| Parameter | Result |
| Antimalarial activity at 5000 µg/ml | 94.3% elimination |
| Antimalarial activity at 2000 µg/ml | 92.9% elimination |
| Antimalarial activity at 500 µg/ml | 91.4% elimination |
| Phytochemicals detected | Saponins, flavonoids, steroids, tannins, alkaloids |
The study concluded that the plant extracts contain active compounds with substantial antimalarial properties, justifying their traditional use.
2.6 Plants with Antimalarial Potential from Northern Nigeria
A comprehensive review identified 30 distinct plant species traditionally used for malaria treatment across Northern Nigeria, highlighting the region’s rich ethnobotanical heritage. These documented uses, along with their phytochemical compositions and therapeutic potentials, provide valuable insights for future drug discovery and sustainable healthcare practices.
2.7 Commonly Used Nigerian Antimalarial Plants
Beyond the scientifically validated formulations, numerous plants are widely used in Nigerian traditional medicine for malaria management:
| Plant Name | Common Name | Scientific Evidence | Traditional Use |
| Vernonia amygdalina | Bitter leaf | Studied by RITAM; known antiplasmodial activity | Decoction for fever |
| Azadirachta indica | Neem | Major constituent of “Herb 25”; widely studied | Tea/infusion for malaria |
| Cajanus cajan | Pigeon pea | Used widely in Nsukka, Enugu State for malaria | Leaf decoctions |
| Markhamia tomentosa | Demonstrated high chemo-suppression | Traditional malaria treatment | |
| Polyalthia longifolia | High chemo-suppression activity | Traditional remedy | |
| Trichilia heudelotii | High chemo-suppression activity | Traditional malaria treatment | |
| Swietenia macrophylla | Mahogany | Excellent antiplasmodial activity (Kano study) | Bark preparations |
| Anisopus manni | Significant antiplasmodial activity | Root preparations | |
| Anogeissus leiocarpus | Significant antiplasmodial activity | Bark preparations |
3. Modes of Administration in Nigerian Traditional Practice
3.1 Common Preparation Methods
Traditional malaria remedies are prepared and administered through various methods:
| Preparation Method | Description | Examples |
| Decoction | Boiling plant material in water to extract active compounds | Eugenia uniflora, Agbo-iba preparations |
| Infusion | Steeping plant material in hot water (similar to tea) | Herb 25″, Neem tea |
| Maceration | Soaking plant material in water or alcohol for extended periods | Jatropha curcas extracts |
| Powdered formulations | Dried plant material ground and encapsulated | SAABMAL® capsules |
| Polyherbal combinations | Mixtures of multiple plants for synergistic effect | HHA, SAABMAL®, Agbo-iba |
3.2 Factors Influencing Use
A cross-sectional study in Nsukka, Enugu State, involving 400 respondents, revealed important patterns in herbal remedy use:
- Rural vs. urban: Rural residents relied more on herbal remedies due to accessibility, affordability, and family traditions
- Urban patterns: Despite higher education levels, urban respondents also used herbal extracts and often alternated them with prescription drugs
- Key predictors: Residence, occupation, and age were significant predictors of knowledge and use (P < 0.05), whereas education was not
- Perceived efficacy: High prescription costs and perceived effectiveness further sustained herbal use
In Bichi Local Government Area of Northern Nigeria, a study of nursing mothers found that 98% knew about medicinal plants, 74% utilized them, and 47% used them exclusively, while 26% used them in addition to orthodox medication. The primary drivers were socioeconomic status (45% unemployed, 30% lacked formal education), beliefs that medicinal plants were more effective than orthodox medicine, and easy accessibility.
4. Comparative Analysis: Herbal vs. Orthodox Therapy
4.1 Key Differences
| Aspect | Herbal Therapy | Orthodox Therapy (ACTs) |
| Active constituents | Multiple compounds, plant-based | Single or few synthetic compounds |
| Mechanism of action | Synergistic action of multiple constituents | Targeted, specific molecular action |
| Resistance development | Lower probability due to multi-component nature | Higher risk of parasite resistance |
| Cost | Generally more affordable | Often expensive, especially ACTs |
| Accessibility | Widely available, locally sourced | Requires healthcare infrastructure and supply chains |
| Standardization | Variable, often lacking formal quality control | Strict pharmaceutical standards |
| Evidence base | Primarily traditional use; growing scientific validation | Extensive clinical trial evidence |
4.2 Integration Challenges
While herbal medicine plays a vital role in healthcare, standardization, safety concerns, and regulatory gaps persist. Key challenges include:
- Quality control: Variable potency and potential contamination
- Safety assessment: Limited toxicological data for many remedies
- Drug interactions: Potential interference with orthodox medications
- Dosage standardization: Inconsistent dosing in traditional preparations
- Regulatory framework: Need for enhanced regulation of herbal products
5. The Research Initiative on Traditional Antimalarial Methods (RITAM)
The Research Initiative on Traditional Antimalarial Methods (RITAM) , established in 1999, has been pivotal in advancing research on traditional antimalarial treatments. This initiative has:
- Created guidelines for standardizing and enhancing ethnobotanical research, therapeutic approaches, and clinical studies on herbal antimalarial drugs
- Conducted systematic reviews and studies on herbs such as Vernonia amygdalina, Cinchona, Argemone mexicana, and Azadirachta indica
- Demonstrated that herbs frequently used by traditional healers have shown significantly higher efficacy in both in vitro and in vivo studies against Plasmodium species compared to those used less frequently or not at all
6. Lessons from Global Success: Artemisinin and Beyond
The story of artemisinin—the most potent antimalarial agent isolated from Artemisia annua (sweet wormwood)—provides a powerful example of what is possible through investment in traditional medicine. Qing hao has been used in Traditional Chinese Medicine for centuries. Its active compound was isolated in 1971 following China’s Project 523, a military-led initiative that systematically investigated traditional remedies for malaria.
Key lessons for Nigeria:
- Investment matters: Significant breakthroughs can emerge from deliberate investment in traditional medicine research
- Scientific rigor: Systematic bioassay-guided fractionation is essential for identifying active compounds
- Documentation: Traditional knowledge must be properly documented and preserved
- Regulatory pathways: Clear pathways for approving herbal medicines are needed
The WHO no longer supports the use of non-pharmaceutical forms of Artemisia annua for treating malaria to preserve the lifespan of artemisinin (the core component of Artemisinin-based Combination Therapies), highlighting the importance of scientific assessment and regulation.
7. Holistic and Complementary Therapies
7.1 Prevention Strategies
Beyond treatment, traditional practices emphasize prevention:
- Environmental management: Clearing standing water where mosquitoes breed
- Use of repellent plants: Growing Neem, lemongrass, and other mosquito-repelling plants around homes
- Bed net use: Both conventional and herbal-treated nets
- Screening of windows and doors: A traditional practice adapted with modern materials
7.2 Supportive Therapies
Nutritional Support
- Iron-rich foods to combat malaria-related anaemia
- Vitamin C-rich fruits to support immune function
- Traditional soups and broths for hydration and nourishment
Fever Management
- Tepid sponging and hydration (a practice common across Nigerian cultures)
- Rest and isolation during acute febrile episodes
7.3 Integration into Primary Healthcare
Several African nations have made significant strides in integrating traditional medicine into national health systems:
| Country | Progress |
| Ghana | Traditional remedies included in National Essential Medicines List (NEML); Traditional Medicine Practice Council regulates practitioners |
| Nigeria | National Policy on Traditional Medicine promotes collaboration between traditional and biomedical practitioners; NAFDAC regulates herbal products |
| South Africa | Indigenous Knowledge Systems policy recognizes traditional healers and emphasizes preservation of indigenous medical knowledge |
8. Safety Considerations and Recommendations
8.1 Important Safety Cautions
| Concern | Recommendation |
| Lack of standardization | Use only products with NAFDAC registration where possible |
| Potential toxicity | Some plants may be hepatotoxic or nephrotoxic at high doses |
| Drug interactions | Herbal remedies may interact with antimalarials, antiretrovirals, or other medications |
| Pregnancy and lactation | Many herbs should be avoided; consult healthcare providers |
| Severe malaria | Herbal remedies should NOT replace ACTs for severe or complicated malaria |
8.2 Recommendations for Safe Use
- Seek proper diagnosis through microscopy or Rapid Diagnostic Tests (RDTs) before treatment
- Consult healthcare practitioners for severe or complicated malaria
- Use standardized products with NAFDAC registration where possible
- Inform healthcare providers about any herbal remedies being used
- Monitor for adverse effects and seek medical attention if symptoms worsen
- Follow recommended dosages and avoid exceeding traditional dosing
9. Research Gaps and Future Directions
The literature reveals several critical areas requiring further investigation:
9.1 Research Needs
| Area | Priority |
| Human clinical trials | Most evidence from animal models; human safety and efficacy data needed |
| Standardized dosing protocols | Defined dosing for herbal formulations |
| Safety and toxicology profiles | Long-term safety data for commonly used herbs |
| Pharmacokinetic studies | Understanding absorption, distribution, metabolism, and elimination of active compounds |
| Drug interaction studies | Interactions between herbal remedies and ACTs or other medications |
| Synergy studies | Understanding how polyherbal combinations work together |
| Quality control methods | Developing simple, affordable quality assurance methods |
| Phytochemical characterization | Identifying and characterizing active compounds |
9.2 Policy Recommendations
Based on the available literature, the following policy actions are recommended:
- Increase funding for traditional medicine research in Nigeria
- Enhance regulatory capacity of NAFDAC for herbal products
- Promote collaboration between traditional practitioners and biomedical researchers
- Document and preserve traditional knowledge through formal pharmacopoeias
- Integrate traditional medicine into primary healthcare systems
- Develop education programs for healthcare workers on traditional medicine
- Support cultivation and sustainable harvesting of medicinal plants
- Establish quality assurance systems for herbal products
10. Conclusion
Malaria remains a formidable health challenge in Nigeria, where it accounts for over a quarter of global cases and nearly a third of African deaths. The convergence of drug resistance, limited healthcare access, and socioeconomic constraints has sustained the central role of traditional medicine in malaria management across Nigerian communities.
Scientific research is increasingly validating the efficacy of Nigerian herbal remedies:
- SAABMAL® has demonstrated antimalarial activity comparable to chloroquine in preclinical studies, with the added benefit of extended survival in treated animals
- “Herb 25” represents a successful model of herbal product development and NAFDAC registration, with a confirmed phytochemical profile
- Agbo-iba formulations, though variable in composition, show potential for synergistic action through multiple plant constituents, with Annickia affinis emerging as a particularly promising source of antimalarial compounds
- Numerous individual plants including Eugenia uniflora, Jatropha curcas, and Azadirachta indica have demonstrated antimalarial activity, supporting their traditional use
The path forward requires increased investment in traditional medicine research, drawing inspiration from global successes like artemisinin from Chinese traditional medicine. As Nigeria faces the highest malaria burden globally, integrating evidence-based traditional practices into national health systems, enhancing regulatory frameworks, and preserving ethnomedicinal knowledge offer promising strategies for strengthening the fight against malaria and advancing toward sustainable health outcomes.
11. References
- Obidike IC, Amodu B, Emeje MO. Antimalarial properties of SAABMAL®: an ethnomedicinal polyherbal formulation for the treatment of uncomplicated malaria infection in the tropics. Indian Journal of Medical Research. 2025.
- Investing in traditional medicine: leveraging evidence and innovative research to strengthen the fight against malaria in Nigeria. Malaria Journal. 2025;24:232.
- Garba AA. In Vitro Antiplasmodial Activity of Antimalarial Herbal Mixture (Agbo), Sold in Kano, Nigeria. Bayero University, Kano. 2025.
- Investing in traditional medicine: leveraging evidence and innovative research to strengthen the fight against malaria in Nigeria. Malaria Journal. 2025;24:232 [PMC Version].
- Aladesanmi AJ, Odediran SA, Oriola AO, et al. Some antimalarial constituents from the leaf of Eugenia uniflora Linn. (Myrtaceae). Nigerian Journal of Natural Products and Medicine. 2025;28(1).
- Suleiman Jada Y, Umar M, Usman MM, Wurochekke AU. Medicinal Plants with Antimalarial Potentials from Northern Nigeria: A Review. Trends in Pharmaceutical Sciences. 2024;10(1):1-14.
- Moke MO. Orthodox and Herbal Therapy of Malaria. Delta State University, Abraka. 2025.
- Tanimu Y, Adamu AA, Nuhu H. Phytochemical Evaluation of “Herb 25” A Herbal Anti-Malarial Product by Gas Chromatographic-Mass Spectrometric Analysis (GC-MS). Taraba State University. 2025.
- Osayi EE, Urama DC, Amujiri AN, et al. Family traditions, accessibility and cost shape the continued reliance on Cajanus cajan and Azadirachta indica for malaria and typhoid despite prescription medicines in urban and rural Nsukka, Nigeria. BMC Complementary Medicine and Therapies. 2026.
- Sani A, Kabir A. In-vitro Antimalarial Activity and Phytochemical Screening of Jatropha curcas Leaf Extracts. Umaru Musa Yar’adua University, Katsina. 2025.
- Adamu SU, Bappah MA, Dickson LC, Sada SA. Medicinal Plants Used by Nursing Mothers for the Treatment of Children Diseases (Diarrhea and Malaria) in Bichi Northern Nigeria. Pakistan Journal of Health Sciences. 2024:97-101.
- Erhunse N, Omoregie ES, Sahal D. Antiplasmodial and antimalarial evaluation of a Nigerian hepta-herbal Agbo-iba decoction: Identification of magic bullets and possible facilitators of drug action. Journal of Ethnopharmacology. 2022.